Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-15-006507
Filing Date
2015-02-17
Accepted
2015-02-17 20:44:22
Documents
1
Period of Report
2015-02-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 14976
  Complete submission text file 0001127602-15-006507.txt   16516
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 15625629